From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria

The repurposing potential of Efavirenz (EFV), a clinically established non-nucleoside reverse transcriptase inhibitor, was comprehensively evaluated for its in vitro antibacterial effect either alone or in combination with other antibacterial agents on several Gram-positive clinical strains showing...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ezzeldin Saleh, Omar A. Soliman, Nancy Attia, Nouran Rafaat, Daniel Baecker, Mohamed Teleb, Abeer Ghazal, Ahmed Noby Amer
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-07-01
Saila:	Molecules
Gaiak:	antibacterial activity Efavirenz drug repurposing in silico binding study
Sarrera elektronikoa:	https://www.mdpi.com/1420-3049/30/14/2925
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!